The race for drug approvals: hasten slowly?

Suppr

超能文献

作者信息

Braillon Alain

机构信息

University Hospital, 80000, Amiens, France.

出版信息

Eur J Clin Pharmacol. 2018 Sep;74(9):1197-1198. doi: 10.1007/s00228-018-2490-9. Epub 2018 May 22.

DOI:10.1007/s00228-018-2490-9

PMID:29789869

Abstract

摘要

相似文献

The race for drug approvals: hasten slowly?

Eur J Clin Pharmacol. 2018 Sep;74(9):1197-1198. doi: 10.1007/s00228-018-2490-9. Epub 2018 May 22.

Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014.未经随机对照研究的药品监管批准：对欧洲药品管理局（EMA）和美国食品药品监督管理局（FDA）1999 - 2014年批准情况的分析

BMJ Open. 2016 Jun 30;6(6):e011666. doi: 10.1136/bmjopen-2016-011666.

End points and United States Food and Drug Administration approval of oncology drugs.肿瘤药物的终点指标及美国食品药品监督管理局的批准

J Clin Oncol. 2003 Apr 1;21(7):1404-11. doi: 10.1200/JCO.2003.08.072.

Priority review drugs approved by the FDA and the EMA: time for international regulatory harmonization of pharmaceuticals?美国食品药品监督管理局（FDA）和欧洲药品管理局（EMA）批准的优先审评药物：是时候实现药品国际监管协调了吗？

Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):709-15. doi: 10.1002/pds.3793. Epub 2015 May 27.

Clin Cancer Res. 2014 Mar 15;20(6):1445-52. doi: 10.1158/1078-0432.CCR-13-1761.

A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs.美国食品药品监督管理局（FDA）、欧洲药品管理局（EMA）和瑞士药品监管局（Swissmedic）批准的新药对比：药品国际协调评估

Eur J Clin Pharmacol. 2018 Jun;74(6):811-818. doi: 10.1007/s00228-018-2431-7. Epub 2018 Feb 22.

Accelerated approval of oncology products: the food and drug administration experience.肿瘤学产品的加速审批：美国食品和药物管理局的经验。

J Natl Cancer Inst. 2011 Apr 20;103(8):636-44. doi: 10.1093/jnci/djr062. Epub 2011 Mar 21.

Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.通过开发已批准药物的新用途进行创新：补充适应症营销批准的趋势。

Clin Ther. 2013 Jun;35(6):808-18. doi: 10.1016/j.clinthera.2013.04.004. Epub 2013 May 28.

Use of multiple endpoints and approval paths depicts a decade of FDA oncology drug approvals.多终点和审批途径的使用描绘了 FDA 肿瘤药物批准的十年历程。

Clin Cancer Res. 2013 Jul 15;19(14):3722-31. doi: 10.1158/1078-0432.CCR-13-0316. Epub 2013 May 10.

FDA and EMA Biosimilar Approvals.美国食品药品监督管理局和欧洲药品管理局的生物类似药批准情况。

J Gen Intern Med. 2020 Jun;35(6):1908-1910. doi: 10.1007/s11606-019-05408-6. Epub 2019 Oct 21.

引用本文的文献

Response to the letter to the Editor regarding Zeukeng et al.'s article A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs.对致编辑的信的回复，该信涉及泽肯等人的文章《美国食品药品监督管理局、欧洲药品管理局和瑞士药品管理局批准的新药比较：药品国际协调评估》。

Eur J Clin Pharmacol. 2018 Sep;74(9):1199-1200. doi: 10.1007/s00228-018-2486-5. Epub 2018 May 26.

本文引用的文献

Eur J Clin Pharmacol. 2018 Jun;74(6):811-818. doi: 10.1007/s00228-018-2431-7. Epub 2018 Feb 22.

Ten years too long: strontium ranelate, cardiac events, and the European Medicines Agency.十年太久：雷奈酸锶、心脏事件与欧洲药品管理局。

BMJ. 2016 Sep 30;354:i5109. doi: 10.1136/bmj.i5109.

Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival: An Analysis of 5 Years of US Food and Drug Administration Approvals.基于替代终点及后续总生存期获批的抗癌药物：对美国食品药品监督管理局5年获批情况的分析

JAMA Intern Med. 2015 Dec;175(12):1992-4. doi: 10.1001/jamainternmed.2015.5868.

Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis.已导致死亡的药品在上市后撤市的延迟情况：一项系统调查与分析

BMC Med. 2015 Feb 5;13:26. doi: 10.1186/s12916-014-0262-7.

The withdrawal of drugs for commercial reasons: the incomplete story of tositumomab.因商业原因撤市的药物：托西莫单抗的不完整故事

JAMA Intern Med. 2014 Dec;174(12):1887-8. doi: 10.1001/jamainternmed.2014.5756.

Surrogate outcomes in clinical trials: a cautionary tale.临床试验中的替代结局：一则警示故事。

JAMA Intern Med. 2013 Apr 22;173(8):611-2. doi: 10.1001/jamainternmed.2013.3037.

Accelerated approval of oncology products: the food and drug administration experience.肿瘤学产品的加速审批：美国食品和药物管理局的经验。

J Natl Cancer Inst. 2011 Apr 20;103(8):636-44. doi: 10.1093/jnci/djr062. Epub 2011 Mar 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验